Trial Pre-Mortem

A clinical-trial pre-mortem agent: it tells a drug developer whether a trial is worth running and where it will die - then says "run this" or "do not run." - potentially saving hundreds of millions of dollars and letting clinical trial developers focus on better designs or repurposing efforts.